ES532641A0 - Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide - Google Patents

Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide

Info

Publication number
ES532641A0
ES532641A0 ES532641A ES532641A ES532641A0 ES 532641 A0 ES532641 A0 ES 532641A0 ES 532641 A ES532641 A ES 532641A ES 532641 A ES532641 A ES 532641A ES 532641 A0 ES532641 A0 ES 532641A0
Authority
ES
Spain
Prior art keywords
heparinoid
antithrombin iii
heparin
iii
antithrombine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES532641A
Other languages
English (en)
Other versions
ES8602414A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG
Publication of ES532641A0 publication Critical patent/ES532641A0/es
Publication of ES8602414A1 publication Critical patent/ES8602414A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
ES532641A 1983-05-20 1984-05-18 Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide Expired ES8602414A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0185983A AT379310B (de) 1983-05-20 1983-05-20 Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates

Publications (2)

Publication Number Publication Date
ES532641A0 true ES532641A0 (es) 1985-12-01
ES8602414A1 ES8602414A1 (es) 1985-12-01

Family

ID=3522546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532641A Expired ES8602414A1 (es) 1983-05-20 1984-05-18 Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide

Country Status (8)

Country Link
US (1) US4510084A (es)
EP (2) EP0307002B1 (es)
JP (2) JPS59222421A (es)
AT (3) AT379310B (es)
CA (1) CA1211371A (es)
DE (2) DE3485288D1 (es)
DK (2) DK167271B1 (es)
ES (1) ES8602414A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58180162A (ja) * 1982-04-19 1983-10-21 株式会社高研 抗血栓性医用材料
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
CA1341379C (en) * 1988-04-28 2002-07-23 Welfide Corporation Purified antithrombin-iii and methods of producing the same
JP2678249B2 (ja) * 1988-06-22 1997-11-17 株式会社ミドリ十字 アンチトロンビン−▲ｉｉｉ▼製剤
WO1994022471A1 (en) * 1993-04-05 1994-10-13 The Green Cross Corporation Liquid antithrombin iii preparation and method of stabilizing the same
JPH08199580A (ja) * 1995-01-24 1996-08-06 Tetra:Kk 斜面昇降装置
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
AT405739B (de) 1997-09-19 1999-11-25 Immuno Ag Verfahren zur reinigung von antithrombin iii
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3099600A (en) * 1961-01-26 1963-07-30 Ormonoterapia Richter Spa Chromatographic purification of heparin
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4119774A (en) * 1976-03-05 1978-10-10 Ab Kabi Heparin purification method
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
JPS6011922B2 (ja) * 1978-09-22 1985-03-29 天野製薬株式会社 高活性ヘパリンの製造法
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
GB2061687B (en) * 1979-11-02 1983-04-13 Kidd A W Grass cutting machines and improved blade therefor
DD148297A1 (de) * 1979-12-21 1981-05-20 Bezirks Inst Fuer Blutspende U Verfahren zur herstellung von prothrombinkomplexkonzentraten mit verminderter thrombogenizitaet
DE3036481A1 (de) * 1980-09-27 1982-05-19 EC Erdölchemie GmbH, 5000 Köln Verfahren zur gemeinsamen herstellung von c 4 -oligomeren und alkyl-tert.-butylethern
US4446126A (en) * 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Antithrombin-heparin complex and method for its production

Also Published As

Publication number Publication date
DK167271B1 (da) 1993-10-04
DK241684A (da) 1984-11-21
DE3485288D1 (de) 1992-01-02
ATE45747T1 (de) 1989-09-15
ATA185983A (de) 1985-05-15
EP0129534B1 (de) 1989-08-23
EP0307002A1 (de) 1989-03-15
DK241684D0 (da) 1984-05-16
JPH07116235B2 (ja) 1995-12-13
DK292090D0 (da) 1990-12-07
EP0129534A3 (en) 1985-12-04
US4510084A (en) 1985-04-09
JPS59222421A (ja) 1984-12-14
ATE69552T1 (de) 1991-12-15
JPH053480B2 (es) 1993-01-14
CA1211371A (en) 1986-09-16
EP0129534A2 (de) 1984-12-27
DE3479503D1 (en) 1989-09-28
DK168062B1 (da) 1994-01-31
JPH05320198A (ja) 1993-12-03
AT379310B (de) 1985-12-27
DK292090A (da) 1990-12-07
ES8602414A1 (es) 1985-12-01
EP0307002B1 (de) 1991-11-21

Similar Documents

Publication Publication Date Title
ES532641A0 (es) Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide
AU564405B2 (en) Production of stabilized whey protein product
AU7264287A (en) A process for the preparation of a factor V concentrate
ES8203610A1 (es) Procedimiento para la fabricacion de un nuevo preparado ac- tivador de la coagulacion de la sangre a base de proteinas humanas
DE3263450D1 (en) Process for the purification of blood coagulation factors ii, vii, ix and/or x and preparations manufactured accordingly
AU587365B2 (en) Pasteurized human fibrinogen (HF), a process for its preparation and its use
PH21834A (en) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
AU3981089A (en) Salt product and method for its preparation
AU591397B2 (en) Method of preparing alpha-1-proteinase inhibitor
ES8100763A1 (es) Procedimiento para la preparacion de concentrado de complejoprotrombinico
IL66496A0 (en) Sulfur-substituted phenoxypyridines having antiviral activity,process for their production and pharmaceutical compositions containing them
ES535409A0 (es) Procedimiento para pasterizar un plasma de radical-humano
MX167398B (es) Procedimiento para pasterizar plasma o concentrados de factores, ii, vii, ix y x de coagulacion de sangre
IL72188A (en) 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
DE3165050D1 (en) Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components
ES524890A0 (es) Metodo de produccion de composiciones que contienen globulina gamma
GB1426039A (en) Haptoglobin in aqueous solution and process for tits preparation
IL72798A0 (en) Process for the preparation of an aqueous solution of sodium chloride
SE8400118D0 (sv) Substituted carboxy-thiazolo(3,2-a)pyrimidine derivatives and process for their preparation
YU116989A (en) Pseudo primycine complexes, components and their additional salts with acids as well as process for making thereof
GB1525815A (en) Texturization of protein
Futami et al. Glycans and glycoproteins in 0.05 M LaCl3-Soluble Fraction from Bovine Costal Cartilage
IE821581L (en) Benzopyrazole derivative in cancer treatment
AR240444A1 (es) Procedimiento para obtener sulfato de aluminio en solucion acuosa.